Cargando…

Autoimmune antibody decline in Parkinson’s disease and Multiple System Atrophy; a step towards immunotherapeutic strategies

BACKGROUND: Parkinson’s’ disease (PD) and Multiple System Atrophy (MSA) are progressive brain disorders characterized by intracellular accumulations of α-synuclein and nerve cell loss in specific brain areas. This loss causes problems with movement, balance and/or autonomic functions. Naturally occu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brudek, Tomasz, Winge, Kristian, Folke, Jonas, Christensen, Søren, Fog, Karina, Pakkenberg, Bente, Pedersen, Lars Østergaard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463400/ https://www.ncbi.nlm.nih.gov/pubmed/28592329 http://dx.doi.org/10.1186/s13024-017-0187-7

Ejemplares similares

Alpha-Synuclein Autoimmune Decline in Prodromal Multiple System Atrophy and Parkinson’s Disease
por: Folke, Jonas, et al.
Publicado: (2022)

Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson’s Disease
por: Folke, Jonas, et al.
Publicado: (2019)

TDP-43–specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis
por: Nielsen, Anne Kallehauge, et al.
Publicado: (2020)

Assessment of brain reference genes for RT-qPCR studies in neurodegenerative diseases
por: Rydbirk, Rasmus, et al.
Publicado: (2016)

Author Correction: Assessment of brain reference genes for RT-qPCR studies in neurodegenerative diseases
por: Rydbirk, Rasmus, et al.
Publicado: (2020)

Increased prefrontal cortex interleukin-2 protein levels and shift in the peripheral T cell population in progressive supranuclear palsy patients
por: Rydbirk, Rasmus, et al.
Publicado: (2019)

Brain proteome profiling implicates the complement and coagulation cascade in multiple system atrophy brain pathology
por: Rydbirk, Rasmus, et al.
Publicado: (2022)

Epigenetic modulation of AREL1 and increased HLA expression in brains of multiple system atrophy patients
por: Rydbirk, Rasmus, et al.
Publicado: (2020)

Cerebellar Cytokine Expression in a Rat Model for Fetal Asphyctic Preconditioning and Perinatal Asphyxia
por: Vlassaks, Evi, et al.
Publicado: (2014)

Immunotherapeutic strategies in autoimmune uveitis
por: Papotto, Pedro Henrique, et al.
Publicado: (2014)

Immunotherapeutic Targeting in Autoimmune Diseases
por: Janikashvili, Nona, et al.
Publicado: (2016)

Passive Immunization in Alpha-Synuclein Preclinical Animal Models
por: Folke, Jonas, et al.
Publicado: (2022)

5-HT(2A) Receptor Binding in the Frontal Cortex of Parkinson's Disease Patients and Alpha-Synuclein Overexpressing Mice: A Postmortem Study
por: Rasmussen, Nadja Bredo, et al.
Publicado: (2016)

Electroconvulsive treatment prevents chronic restraint stress‐induced atrophy of the hippocampal formation—A stereological study
por: Alemu, Johanne L., et al.
Publicado: (2019)

Inflammatory Bowel Diseases and Parkinson’s Disease
por: Brudek, Tomasz
Publicado: (2019)

DNAJB6b is Downregulated in Synucleinopathies
por: Folke, Jonas, et al.
Publicado: (2021)

Restoring the balance: immunotherapeutic combinations for autoimmune disease
por: Smilek, Dawn E., et al.
Publicado: (2014)

Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity
por: von Herrath, Matthias G., et al.
Publicado: (2005)

Immunotherapeutic nanoparticles: From autoimmune disease control to the development of vaccines
por: Mitarotonda, Romina, et al.
Publicado: (2022)

A Perspective on Oral Immunotherapeutic Tools and Strategies for Autoimmune Disorders
por: Shakya, Akhilesh Kumar, et al.
Publicado: (2023)

Modeling the early stages of Alzheimer’s disease by administering intracerebroventricular injections of human native Aβ oligomers to rats
por: Baerends, Eva, et al.
Publicado: (2022)

Multiparity, Brain Atrophy, and Cognitive Decline
por: Jung, Joon Hyung, et al.
Publicado: (2020)

Expression of HERV-H/W env epitopes on PBMCs from MS patients with active disease
por: Brudek, Tomasz, et al.
Publicado: (2011)

The First Step in Adoptive Cell Immunotherapeutics: Assuring Cell Delivery via Glycoengineering
por: Sackstein, Robert
Publicado: (2019)

The impact of maternal separation on adult mouse behaviour and on the total neuron number in the mouse hippocampus
por: Fabricius, Katrine, et al.
Publicado: (2008)

Application of Immunohistochemistry in Stereology for Quantitative Assessment of Neural Cell Populations Illustrated in the Göttingen Minipig
por: Hou, Jack, et al.
Publicado: (2012)

Stereological estimation of total cell numbers in the human cerebral and cerebellar cortex
por: Walløe, Solveig, et al.
Publicado: (2014)

Regional brain atrophy and cognitive decline depend on definition of subjective cognitive decline
por: Morrison, Cassandra, et al.
Publicado: (2021)

Absence of xenotropic murine leukaemia virus-related virus in Danish patients with multiple sclerosis
por: Maric, Romana, et al.
Publicado: (2011)

In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson’s disease
por: Ray, Nicola J, et al.
Publicado: (2018)

Striking reduction in neurons and glial cells in anterior thalamic nuclei of older patients with Down syndrome
por: Perry, James C., et al.
Publicado: (2019)

The Optical Fractionator Technique to Estimate Cell Numbers in a Rat Model of Electroconvulsive Therapy
por: Olesen, Mikkel Vestergaard, et al.
Publicado: (2017)

Untreated Patients Dying With AIDS Have Loss of Neocortical Neurons and Glia Cells
por: Kaalund, Sanne Simone, et al.
Publicado: (2020)

Clinical Profile of Cognitive Decline in Patients with Parkinson's Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy
por: Sulena,, et al.
Publicado: (2017)

Night blood pressure variability, brain atrophy, and cognitive decline
por: Yu, Ji Hee, et al.
Publicado: (2022)

Association of Regional Atrophy With Naming Decline in Primary Progressive Aphasia
por: Breining, Bonnie L., et al.
Publicado: (2023)

A Mouse Model of Adoptive Immunotherapeutic Targeting of Autoimmune Arthritis Using Allo-Tolerogenic Dendritic Cells
por: Yang, Jie, et al.
Publicado: (2013)

Immunotherapeutic Advancements for Glioblastoma
por: Ampie, Leonel, et al.
Publicado: (2015)

Editorial: Complement and Immunotherapeutics
por: Okrój, Marcin, et al.
Publicado: (2021)

Immunotherapeutic Advances for NSCLC
por: Massafra, Marco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7h3aks47iagj4cp874i6svtjo3